Abstract

Amyloid-β, a hallmark of Alzheimer’s disease, forms toxic intracellular oligomers and extracellular senile plaques resulting in neuronal toxicity. Ethanol is widely consumed worldwide. Moderate ethanol consumption has numerous benefits in humans. We found that ethanol could significantly extend the lifespan of Caenorhabiditis elegans in a previous study. Based on that study, we tested the effect of ethanol on Alzheimer’s disease transgenic Caenorhabiditis elegans strain CL4176, which expresses amyloid-β1-42 peptide in body wall muscle cells. Ethanol delayed paralysis and reduced amyloid-β oligomers in Caenorhabiditis elegans worms of the CL4176 strain. Moreover, ethanol could induce the nuclear translocation of DAF-16 in the nematodes. However, in worms that were fed daf-16 RNAi bacteria, ethanol no longer delayed the paralysis. The qPCR assays showed that ethanol increases the expression of daf-16, hsf-1 and their common target genes- small heat shock protein genes. In addition, we also found that ethanol could increase lysosome mass in the CL4176 worms. In summary, our study indicated that ethanol attenuated amyloid-β toxicity in the Alzheimer’s disease model of Caenorhabiditis elegans via increasing the level of lysosomes to promote amyloid-β degradation and upregulating the levels of small heat shock protein genes to reduce amyloid-β aggregation.

Highlights

  • Alzheimer’s disease (AD), a progressive neurodegenerative disorder, is the main cause of dementia and is one of the major health care challenges of the twenty-first century (Scheltens et al, 2016)

  • We measured the mRNA levels of daf16, hsf-1 and their down-stream genes to determine whether ethanol delayed paralysis through inducing these stress response pathways

  • The qPCR analysis of these genes showed that daf-16 and hsf-1 were upregulated in worms treated with ethanol

Read more

Summary

Introduction

Alzheimer’s disease (AD), a progressive neurodegenerative disorder, is the main cause of dementia and is one of the major health care challenges of the twenty-first century (Scheltens et al, 2016). Neurofibrillary tangles and senile plaques, consisting of hyperphosphorylated tau protein and insoluble amyloid-β (Aβ) peptide, respectively, are the main pathological features in the brains of patients with AD (Qiu et al, 2015). Many researchers have focused on Aβ1-42 as a biomarker to study AD progression and therapy. Caenorhabiditis elegans is a transparent, 1mm long roundworm. Because of their short lifespan and simple physical structure, nematodes are extremely well-suited to study aging diseases in humans (Shen et al, 2018), and many researchers have used a Caenohabiditis elegans model expressing Aβ to study AD. Numerous studies have shown that transgenic C. elegans expressing Aβ peptides can be widely used to screen candidate compounds for alleviating or treating AD

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call